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Abstract
Background: The success of HIV programs relies on widely accessible HIV testing and counseling (HTC) services at health
facilities as well as in the community. Home-based HTC (HB-HTC) is a popular community-based approach to reach persons
who do not test at health facilities. Data comparing HB-HTC to other community-based HTC approaches are very limited.
This trial compares HB-HTC to mobile clinic HTC (MC-HTC).
Methods and Findings: The trial was powered to test the hypothesis of higher HTC uptake in HB-HTC campaigns than in
MC-HTC campaigns. Twelve clusters were randomly allocated to HB-HTC or MC-HTC. The six clusters in the HB-HTC group
received 30 1-d multi-disease campaigns (five villages per cluster) that delivered services by going door-to-door, whereas
the six clusters in MC-HTC group received campaigns involving community gatherings in the 30 villages with subsequent
service provision in mobile clinics. Time allocation and human resources were standardized and equal in both groups. All
individuals accessing the campaigns with unknown HIV status or whose last HIV test was .12 wk ago and was negative
were eligible. All outcomes were assessed at the individual level. Statistical analysis used multivariable logistic regression.
Odds ratios and p-values were adjusted for gender, age, and cluster effect. Out of 3,197 participants from the 12 clusters,
2,563 (80.2%) were eligible (HB-HTC: 1,171; MC-HTC: 1,392). The results for the primary outcomes were as follows. Overall
HTC uptake was higher in the HB-HTC group than in the MC-HTC group (92.5% versus 86.7%; adjusted odds ratio [aOR]:
2.06; 95% CI: 1.18–3.60; p= 0. 011). Among adolescents and adults $12 y, HTC uptake did not differ significantly between
the two groups; however, in children,12 y, HTC uptake was higher in the HB-HTC arm (87.5% versus 58.7%; aOR: 4.91; 95%
CI: 2.41–10.0; p,0.001). Out of those who took up HTC, 114 (4.9%) tested HIV-positive, 39 (3.6%) in the HB-HTC arm and 75
(6.2%) in the MC-HTC arm (aOR: 0.64; 95% CI: 0.48–0.86; p= 0.002). Ten (25.6%) and 19 (25.3%) individuals in the HB-HTC and
in the MC-HTC arms, respectively, linked to HIV care within 1 mo after testing positive. Findings for secondary outcomes
were as follows: HB-HTC reached more first-time testers, particularly among adolescents and young adults, and had a higher
proportion of men among participants. However, after adjusting for clustering, the difference in male participation was not
significant anymore. Age distribution among participants and immunological and clinical stages among persons newly
diagnosed HIV-positive did not differ significantly between the two groups. Major study limitations included the campaigns’
restriction to weekdays and a relatively low HIV prevalence among participants, the latter indicating that both arms may
have reached an underexposed population.
Conclusions: This study demonstrates that both HB-HTC and MC-HTC can achieve high uptake of HTC. The choice between
these two community-based strategies will depend on the objective of the activity: HB-HTC was better in reaching children,
individuals who had never tested before, and men, while MC-HTC detected more new HIV infections. The low rate of linkage
to care after a positive HIV test warrants future consideration of combining community-based HTC approaches with
strategies to improve linkage to care for persons who test HIV-positive.
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Introduction
The success of national HIV programs relies on widely
accessible HIV testing and counseling (HTC) services, which are
the first step towards control of the global HIV/AIDS epidemic
[1–3]. While HTC represents the entry point to antiretroviral
therapy (ART) for those in need, it also acts as a preventive
intervention for those who test negative and for partners of persons
testing HIV-positive and subsequently starting ART [4–6].
However, universal coverage of HTC has not been reached yet.
Uptake of HTC in a standard clinical setting is usually low [7],
particularly among men [8,9]. Further, HTC at clinics remains
limited to persons who attend medical facilities. Several studies
have concluded that HTC provision outside clinical settings
(community-based HTC) is feasible and acceptable and results in a
higher uptake of HTC, particularly among populations that are
usually hard to reach, such as men or first-time testers [7,10–13].
There are different kinds of community-based HTC, including
community gatherings around mobile clinics (mobile clinic HTC
[MC-HTC]) and home-based HTC (HB-HTC). During HB-
HTC, a team—most often consisting of a counselor and a nurse—
goes door-to-door, visiting each household in the community and
offering HTC to the household members. HB-HTC has recently
been advocated by the World Health Organization [14]. The
approach showed high acceptance [15] and is convenient to the
community [16–19]. These qualities result in high uptake within
rural areas and provide access to hard to reach populations [7–
13,20–22]. Sabapathy and colleagues conclude from a systematic
review and meta-analysis of 21 observational studies in five African
countries that HB-HTC could substantially increase awareness of
previously undiagnosed persons about their HIV status [15].
However, there are limited data comparing HB-HTC to
facility-based HTC [22] and—to our knowledge—no randomized
trials comparing HB-HTC to other community-based HTC
delivery approaches such as MC-HTC. A Cochrane review in
2010 concluded that although HB-HTC may have the potential to
scale up HTC in low-resource settings, not enough data were
available to recommend its implementation on a large scale until
studies comparing HB-HTC to more conventional approaches
were conducted [23].
In Lesotho, where the adult HIV prevalence is 23.6% and the
ART coverage rate is only 61% [2,24], strategies to provide
universal HTC are urgently needed. With the aim of testing which
programmatic approach would be more effective for a rural, high-
prevalence setting, this cluster-randomized trial compared two
community-based HTC interventions: HB-HTC and MC-HTC.
Methods
Ethics Statement
The study protocol was approved by the National Research and
Ethics Committee of the Ministry of Health and Social Welfare of
Lesotho. All individuals gave oral and written consent prior to
participating in the study. In the case of children ,18 y of age, the
caregiver gave oral and written consent.
Study Hypothesis, Design, and Setting
The study’s main hypothesis was that the HB-HTC approach
would result in a higher uptake of HTC than the MC-HTC
approach among individuals accessing the multi-disease cam-
paigns.
The study was an open-label, two-armed cluster-randomized
trial conducted in two rural catchment areas of Lesotho (Seboche
Hospital and Paray Hospital) from 17 October to 25 November
2011. The catchment area of Seboche Hospital (district of Butha-
Buthe) in northern Lesotho has an estimated population of 55,000
inhabitants served by five primary health care centers. The
catchment area of the Paray Hospital is in the mountainous district
of Thaba-Tseka in central Lesotho. It has a population of about
77,000 inhabitants served by seven primary health care centers.
HTC services are available in all health centers of the study area.
The population of both districts lives mainly from subsistence
farming. According to the Lesotho Demographic Health Survey
2009, the adult HIV prevalence in Butha-Buthe and Thaba-Tseka
is 15.9% and 20.1%, respectively [24]. The government of
Lesotho estimated in 2009 that 25.7% of adult women who were
HIV-positive and 41% of men who were HIV-positive had never
been tested for HIV [25]. HTC coverage in the two districts is
comparable, with about 60% of adult women and 40% of men
having ever had an HIV test [24]. SolidarMed, a Swiss non-
governmental organization, has been supporting the national HIV
program, including HTC delivery, in the study area since 2005.
With the Know Your Status Campaign, Lesotho introduced a
national concept to standardize HTC services in 2006 [26].
Although the campaign led to an increase in HTC coverage, there
were concerns related to the quality of services, in particular with
regard to obtainment of informed consent, ensuring confidential-
ity, and linkages to services and support [27]. Nevertheless, the
campaign provided an important national framework for task
shifting of HTC from health care professionals to community and
lay counselors, thus allowing delivery of decentralized and
community-based HTC. In Lesotho, community and lay coun-
selors are non-medical personnel who have undergone a 6-wk
standardized training in HTC provided by the Ministry of Health
and Social Welfare (or, since 2012, the Ministry of Health) of
Lesotho. Professional and senior counselors supervise the lay
counselors at the facility and district levels, respectively. In
Lesotho, mainly two community-based HTC approaches are
implemented: HB-HTC and MC-HTC at community gatherings,
locally called ‘‘pitso.’’ The latter has become very common and is
also used to provide preventive medical services such as
immunization, antenatal care consultations, and malnutrition
screening among children.
Allocation and Randomization
Since both HB-HTC and MC-HTC have an impact on the
interaction between individuals of the same community, allocation
and randomization were based on clusters. One health center with
its catchment area formed a cluster. Paray Hospital has seven
health centers affiliated to it, and Seboche Hospital has five. All 12
centers were included in the study, to form 12 clusters. The
clusters were stratified and paired using data from routine HTC
activities at their clinics and subsequently randomized into the two
study groups. Pairing before randomization was based on the
following three indicators from routine monitoring data: monthly
routine facility-based HTC, monthly positive HTC results, and
monthly enrollment in care of persons newly diagnosed HIV-
positive. In addition, the affiliated hospital (Seboche or Paray) was
taken into account during the pairing of clusters. After the pairing
of clusters, pairs were randomized into the two study groups. In
one group, HTC was provided within multi-disease campaigns at
community gatherings around a mobile clinic (MC-HTC group).
In the other group, HTC was provided within the same multi-
disease campaigns, but using a door-to-door approach (HB-HTC
group).
During the official kick-off meeting with the study teams and
representatives of both districts, an independent person randomly
allocated clusters by means of throwing a coin. As a result, six
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clusters (one of each pair) were assigned to the HB-HTC group,
while the other six were assigned to the MC-HTC group. Before
random allocation of the clusters to the interventions, the team of
each health center provided a list with ten villages within its
catchment area eligible for an HTC campaign according to the
following criteria: villages with at least 25 households that were
geographically clearly confined to the catchment area and located
at a distance of three to 20 km from the facility. Five of the ten
eligible villages in each cluster were randomly selected to receive
the intervention; the other five served as control villages, with no
HTC campaign held during the study period. The numbers of
individuals newly tested HIV-positive residing in the control
villages of both groups and identified through routine facility-
based HTC in both study groups were collected as part of the
descriptive cluster analysis during a period of 28 d after the
campaigns held in the intervention villages.
Within each cluster, the health center conducted a 1-d HTC
campaign (MC-HTC or HB-HTC) in each of the five selected
villages, resulting in five 1-d campaigns per cluster and 30
campaigns per study arm. Within each cluster pair, the five HTC
campaigns per cluster were held simultaneously. The duration of
the intervention phase was therefore 6 wk, and the total number of
HTC campaigns performed was 60.
Services Provided during the Campaigns
Irrespective of the study arm, services provided during all HTC
campaigns followed the principle of a multi-disease campaign and
included the following: clinical tuberculosis screening and mea-
surement of weight and height for all individuals, family planning,
blood pressure and blood sugar measurement for adults, and
provision of vitamin A, standard immunizations, and deworming
for eligible children and women. In line with general practice in
the country, HTC was performed by trained lay counselors under
supervision of the hospital’s professional counselor as well as the
district’s senior counselor. HTC followed the national guidelines
[27]. Testing was done with Alere Determine. In the case of a
positive result, the test was confirmed by Alere DoubleCheck
Gold. In case of incongruence between Alere Determine and Alere
DoubleCheck Gold, SD Bioline HIV was used as a third test. In
the case of a confirmed positive HIV test result, CD4 count was
determined on site, using a point-of-care CD4 test (Alere Pima).
Clinical WHO staging was done by the nurse on site. During the
whole process of pre-test counseling, testing, and post-test
counseling, the participant and counselor stayed together in the
same room in order to ensure that all participants who took up
HTC received full HTC including post-test counseling. In
compliance with the national guidelines, the name, age, and
village of participants who took up HTC were registered in the
national HTC registers. In addition, participants received a study
number in order to allow anonymous processing of data. After
post-test counseling, persons newly detected as HIV-positive were
referred to their nearest health center using the national standard
referral form. If they agreed, their names, addresses, and cell-
phone numbers—if available—were noted and sent to the health
center to allow tracing in case they did not enroll for care within
1 mo after their test.
Human Resources and Time Allocation during the
Campaigns
Human resources and time allocation were equal in both study
arms. Each campaign was conducted by a team of five persons:
one professional counselor, two nurses, and two lay counselors.
This team divided into two sub-teams of one lay counselor and one
nurse who provided the services together. The two sub-teams were
supervised by the professional counselor. The campaigns started at
9:00 A.M. and lasted until 5:00 P.M. The time slot was limited
because of feasibility issues. First, travel time to some of the villages
was as long as 2.5 h for the study team. Second, the lack of
electricity in most villages included in the study forced the
campaigns to take place during daylight. To adapt the study as
much as possible to the real-life setting of the daily work routine at
health centers, campaigns were not held on weekends. In order to
minimize the effect of individual team members on the outcomes,
the teams rotated between the study-arms—meaning that one
team ran campaigns in the HB-HTC group in one week and in the
MC-HTC group the next week, and so on.
Intervention
The MC-HTC group provided services through ‘‘pitso’’—the
more routine HTC approach in Lesotho. ‘‘Pitso’’ is a community
gathering, usually held at the chief’s place. One week prior to the
scheduled date of the campaign, the health centers informed the
villagers via their chiefs about the planned community gathering
with provision of HTC and other services. The day of the
campaign, community members gathered to listen to a health talk
given by a primary health care nurse aimed at sensitizing listeners
to HIV as well as other health issues. After the talk, all participants
of the community gathering were invited to access the services in
one of two tents installed next to the chief’s place. Persons
interested queued in front of the tent, entering one by one to
receive the sought services. Families and couples were allowed to
enter the tent together to receive services simultaneously, if they
wished. Inside the tent, one lay counselor and one nurse offered all
services of the multi-disease campaign as listed above. The
participant was free to accept or refuse any of the offered services.
For example, a person was able to enter the tent and accept blood
pressure and blood glucose measurement, but refuse HTC and all
other services.
Identically to the MC-HTC group, villagers in villages assigned
to the HB-HTC group were informed about the campaign 1 wk
prior to the scheduled date. However, in the HB-HTC group
there was no community gathering or health talk. After arrival at
the village and a formal visit to the chief, the two sub-teams—each
consisting of one lay counselor and one nurse—started from the
chief’s place and provided all the services at people’s homes, going
door-to-door towards the periphery of the village. Services were
usually provided to all persons living in the same household at the
same time. If nobody was at home, the teams moved to the next
house. Identical to the MC-HTC approach, individuals were free
to choose the services they wished to receive out of the offered
package of the multi-disease campaign.
During both intervention approaches, a professional counselor
supervised the two sub-teams. The sub-teams called the profes-
sional counselor in case of technical difficulties or if they
encountered particular psycho-social problems during or after
testing. Participants received no incentives, neither for participat-
ing in the study nor for accepting HTC.
Eligibility of Study Participants
All persons resident within the study area and not known to be
HIV-positive were eligible. Children ,18 y who were not
accompanied by their caregiver to provide consent for participa-
tion in the study were excluded. Persons with a documented last
negative HIV test dated less than 12 wk ago were excluded from
HTC, as national HTC guidelines recommend a 12-wk period
before re-testing after a negative HIV test. Ethics approval was
obtained from the National Research and Ethics Committee of the
Ministry of Health and Social Welfare of Lesotho. Participants
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gave written and oral consent for their data to be analyzed
anonymously and could exit the study at any point while
continuing to access and receive the same services. Data were
kept and processed confidentially.
Outcomes at the Individual Level
The trial had three primary and five secondary outcomes. The
first primary outcome was the number of persons taking up HTC.
All eligible individuals accessing the multi-disease campaigns were
offered HTC. Uptake was defined as acceptance and completion
of HTC with pre-test counseling, HIV test, and post-test
counseling. The second primary outcome was the proportion of
participants newly tested HIV-positive among participants who
took up HTC. Participants who reported that they had never
received a positive HIV test result prior to the planned HTC and
who tested subsequently HIV-positive were defined as newly tested
HIV-positive. The third primary outcome was linkage to care
within 28 d after a positive HIV test among participants who
tested HIV-positive during the campaign. Participants who tested
positive were referred to their nearest health center. One month
later, the study team checked the pre-ART and ART registers of
the facilities in the study area to see whether individuals had linked
to chronic care within 28 d.
The first secondary outcome was the age group distribution of
persons accessing the campaigns (,12, 12–24, and $25 y). The
second secondary outcome was the proportion of first-time testers
among people who took up HTC. ‘‘First-time tester’’ was defined
as an individual reporting never having had an HIV test before
and taking up HTC during the campaigns. The third secondary
outcome was male participation. This outcome is reported in two
ways: the proportion of men among all individuals who accessed
the campaigns, and the proportion of men who took up HTC
during the campaigns among all persons who accessed the
campaigns. The fourth secondary outcome was the clinical
WHO stage of participants newly diagnosed HIV-positive, as
assessed by the study nurse during the campaign. The fifth
secondary outcome was the CD4 cell count among participants
newly diagnosed HIV-positive, measured on site with a point-of-
care CD4 test (Alere Pima). With the exception of the third
primary outcome, the nurse of each sub-team collected all data
during the campaign, using a paper-based reporting form. Correct
filling-in of the reporting form was described in standardized
procedures. The nurses had been trained during four 1-d HTC
campaigns prior to the study. Outcomes for other services
provided during the multi-disease campaigns will be reported
separately.
Outcomes at the Cluster Level
One month after the end of the five campaigns per cluster, the
study team assessed the number of persons who tested HIV-
positive through routine facility-based HTC during the 28 d
following the campaign in the specific cluster by reviewing the
HTC register of the respective facility. The rationale was to
identify whether a larger number of individuals—especially those
at risk of HIV infection—sought HTC at their clinic as a result of
sensitization through the campaigns. Aggregate data at the cluster
level were collected separately for individuals residing in one of the
five control villages who tested HIV-positive through routine HTC
and overall individuals who tested positive within the cluster.
Post Hoc Cost Analysis
In Table S1, we report the costs related to the 60 campaigns
held during the study. Costs are reported based on the actual
expenditures made for each component of the campaign. The
initial budget was in maloti (LSL) and then transformed into US
dollars using the exchange rate of September 2011 (1
LSL=US$0.12). Amortization of the two 464 vehicles used
during the campaign was budgeted as being 8.5 LSL (US$1.02)
per kilometer, based on real costs. Cost analysis was not part of the
initial trial protocol.
Sample Size and Statistical Analysis
The trial was designed and powered to measure outcomes at the
individual level. The sample size was determined by the formula
proposed by Hayes and Bennett [28]. From the experience of
former HTC campaigns using the MC-HTC approach, we
estimated that HTC uptake would be about 65% in the MC-
HTC arm. The estimated difference was anticipated to be 15%
(10% to 20%) in favor of HB-HTC. With an expected inter-cluster
coefficient k of 0.1, six clusters per arm with 200 individuals per
cluster would be needed to achieve a statistical power of 80% at a
significance level of 5%. After completion of the trial, the
calculated inter-cluster coefficient k was 0.04 for the first primary
outcome. For the second primary outcome (newly detected HIV
infections), k was close to zero, indicating that there was no
relevant inter-cluster variance. Considering the measured differ-
ence in HIV prevalence in both arms, post hoc sample size
computation for the second primary outcome indicated that 192
individuals per cluster were needed to achieve a statistical power of
80%. Analyses were run on STATA 12.1 (StataCorp).
All reported adjusted odds ratios (aORs) take into account a
potential correlation between the estimated errors within the same
cluster (cl option in STATA). In addition, all aORs and p-values
are adjusted for gender and age group (,12 y, 12–24 y, and $
25 y)—except for analyses stratified by age group or gender, where
adjustment is done only for gender and cluster or age group and
cluster, respectively. Because the national HTC guidelines of
Lesotho require consent of the caregiver to test children ,12 y of
age, a separate analysis was performed for the first primary
outcome, disaggregated by age group (distinguishing between
children ,12 y, adolescents and young adults 12–24 y, and adults
$25 y). Median CD4 values from participants newly diagnosed as
HIV-positive were compared using the Mann-Whitney U test.
Outcomes from aggregate data at the cluster level are reported
descriptively.
Deviations from Initial Trial Registration
Aggregate data from clusters on numbers of persons newly
tested HIV-positive through routine facility-based HTC during
the 28 d following the study campaigns were initially registered as
one of the primary outcomes. While finalizing the internal study
protocol, cluster data were dropped as a primary outcome because
the trial was designed and powered to measure differences in
outcomes at the individual level and not at the cluster level. Only
individual endpoints were kept as primary outcomes—uptake of
HTC, participants newly detected HIV-positive, and subsequent
enrollment in HIV care—as these endpoints represent the three
major steps of the HTC cascade. Nevertheless, description of
cluster data was maintained and is reported in this paper.
Results
Enrollment and Participants
Characteristics of randomized clusters are displayed in Table 1.
Figure 1 shows the enrollment, exclusion, and flow of the patients
in both study arms. The HB-HTC campaigns provided services to
1,433 individuals, and the MC-HTC campaigns to 1,764
individuals. Overall, 634 individuals were excluded from the
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analysis due to the predefined exclusion criteria, 262 (18.3%) in
the HB-HTC group, and 372 (21.1%) in the MC-HTC group.
The main reason for exclusion was an already known positive HIV
status. All eligible persons consented to their data being included
in the analysis.
HTC Uptake, Positive Tests, and Linkage to Care
Table 2 displays the three primary outcomes. Overall, the HB-
HTC group achieved a higher uptake of HTC (92.5% versus
86.7%; aOR: 2.06; 95% CI: 1.18–3.60; p=0.011). There was a
significant interaction between age and uptake of HTC (p,0.001):
among children below 12 y of age—where the caregiver has to
approve HTC—uptake was 87.5% in the HB-HTC group,
compared to 58.7% in MC-HTC group (aOR: 4.91; 95% CI:
2.41–10.00; p,0.001). Among participants $12 y of age, uptake
tended to be lower in the HB-HTC group compared to the MC-
HTC group (Table 2). Out of the 2,563 participants in both
groups, 114 (4.4%) tested HIV-positive. Participants in the HB-
HTC group were less likely than participants the MC-HTC group
to test positive: 39 (3.6%) versus 75 (6.2%) (aOR: 0.64; 95% CI:
0.48–0.86; p=0.002) (Table 2).
Pre-ART and ART registers of the 12 clusters were checked for
all 114 patients who tested positive. Ten (25.6%) out of the 39 in
the HB-HTC group and 19 (25.3%) out of the 75 in the MC-HTC
group linked to HIV care at the nearest facility within 1 mo
(Table 2).
Age of Participants, First-Time Testers, and Participation
of Men
The two groups had a similar age distribution (Table 1).
Overall, the proportion of first-time testers was higher in the HB-
HTC group (56.2% versus 44.4%; aOR: 1.57; 95% CI: 1.03–
2.39; p=0.035), in particular among adolescents and young
adults aged 12 to 24 y (53.8% versus 31.3%; aOR: 2.47; 95% CI:
1.49–4.08; p,0.001) (Table 3). The proportion of men was
30.3% and 23.5% in the HB-HTC and MC-HTC groups,
respectively. However, after adjusting for clustering, the differ-
ence was not significant anymore (aOR: 1.41; 95% CI: 0.98–
2.03; p=0.062) (Table 3).
Stage of Disease among Participants Newly Tested HIV-
Positive
Median CD4 count (interquartile range) among participants
newly tested HIV-positive was 438 cells/ml (265–650) in the HB-
HTC group and 400 cells/ml (207–629) in the MC-HTC group
(p=0.491); 39% and 35% had a CD4 count ,350 cells/ml,
respectively (aOR 0.84; 95% CI: 0.28–2.55). Only one participant
in the MC-HTC group and two in the HB-HTC group had a
clinical WHO stage 3 infection. The remaining participants were
staged as WHO stage 1 or 2 (Table 3).
Outcomes at the Cluster Level
During the 28 d that followed the campaigns, 49 individuals
tested HIV-positive in the 12 clusters by visiting routine facility-
based HTC. Seven of those resided in the predefined control
villages of the study (six in control villages of the HB-HTC
intervention and one in a control village of the MC-HTC
intervention). Within the HB-HTC and MC-HTC clusters, 12
and 30 individuals, respectively, were identified as HIV-positive
but resided outside the study villages (intervention and control).
Cost of Campaigns
Table S1 summarizes the expenditures corresponding to the 30
1-d HTC campaigns in each arm. Respective costs in the HB-
HTC and MC-HTC arms were US$17.8 and US$16.2 per
individual who took up HTC, US$495 and US$260 per individual
Table 1. Characteristics of randomized clusters and baseline characteristics of study participants.
Characteristic HB-HTC Group (n=6) MC-HTC Group (n=6)
Median (IQR) catchment population per cluster 6,311 (5,379–7,203) 4,909 (4,267–5,307)
Median (IQR) routine facility-based HTC per cluster in the 3 mo prior to the
study period (Jul–Sept 2011)
Men 42 (35–76.8) 39.5 (31–45.9)
Women 116 (101.5–125.8) 120 (75.8–135.8)
Both sexes 183.5 (140–207.1) 157 (111–164.5)
Median (IQR) number of facility-based positive HIV tests per cluster in the 3 mo
prior to the study period (Jul–Sept 2011)"
12.5 (11.3–12.9) 11.5 (11–11.9)
Number of study participants 1,171 1,392
Age group1
,12 y 296 (25.3%) 356 (25.6%)
12–24 y 208 (17.8%) 207 (14.9%)
$25 y 658 (56.2%) 827 (59.4%)
Age not recorded 9 (0.8%) 2 (0.1%)
Gender*
Women 776 (66.3%) 976 (70.1%)
Gender not recorded 4 (0.3%) 2 (0.1%)
"Data derived from national HTC registers of the 12 health centers in the study area.
1p-Value for age group distribution: 0.88.
*p-Value for gender distribution: 0.044.
IQR, interquartile range.
doi:10.1371/journal.pmed.1001768.t001
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who tested HIV-positive, and US$1,932 and US$1,027 per person
who tested HIV-positive and enrolled in care within 1 mo.
Discussion
This cluster-randomized trial compared two ways of providing
community-based HTC in rural Lesotho: the approach of
community gathering and subsequent HTC in a mobile clinic
(MC-HTC) and the approach of going from door to door and
offering HB-HTC to all household members. The trial was
powered to show a difference in HTC uptake of 15% or more
between the two arms. HB-HTC and MC-HTC had similar
uptake of HTC for adolescents and adults $12 y, but HB-HTC
achieved a significantly higher uptake in children below 12 y of
age. On the other hand, MC-HTC led to more persons being
newly detected as HIV-positive. In both study groups, there was
high attrition of participants between receiving a positive HIV test
result and linkage to care, with only one-quarter presenting at their
local health facility within 1 mo after their positive test result. HB-
HTC and MC-HTC differ in their sampling strategy and
therefore reach different populations. HB-HTC reached more
children, first-time testers, and men, whereas MC-HTC reached
more individuals with a previously undiagnosed HIV infection.
The literature provides conclusive evidence that community-
based HTC is a cost-effective approach to reach populations that
have low access to clinic-based HTC, results in higher uptake of
HTC, and detects more new HIV infections at an asymptomatic
stage [11,12,29]. Only a few observational studies, however, have
compared different approaches of community-based HTC. Our
study therefore adds to the limited evidence.
The study has several limitations. First, available resources
limited the number of clusters included in the study, which
naturally resulted in high standard errors and broad confidence
intervals as all outcomes were adjusted for clustering. Second,
based on routine HTC data in the study area (Table 1) and on the
high overall HIV prevalence in Lesotho, we had assumed a higher
Figure 1. Consort chart of the study. One health center with its catchment area formed a cluster. ITT, intention to treat.
doi:10.1371/journal.pmed.1001768.g001
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proportion of positive HIV test results among study participants.
However, prevalence in the study population turned out to be
lower. Although this may partly be explained by a relatively high
number of individuals accessing the multi-disease campaigns who
had to be excluded because they were already known to be HIV-
positive, addition of these individuals results in a prevalence still
below expected. This indicates that the campaigns may have
reached an underexposed population. Several observational
studies from southern Africa report lower HIV prevalence among
testers during mobile testing campaigns than in clinic testing [30–
35]. However, this should not draw into question the value of
community-based approaches to HTC. Knowing one’s HIV
status—irrespective if positive or negative—carries an important
preventive benefit for the individual as well as for the community
[4]. Another important reason for the low rate of positive HIV
tests in this study may be the limitation of campaigns to a time
frame from 9:00 A.M. to 5:00 P.M. during weekdays. Campaigns
thus did not reach persons working outside the village, and in this
case excluded migrant workers who work in neighboring South
Africa—a group known to be at particularly high risk of HIV
infection [36]. To reach working populations and children or
adolescents who are at school, HTC campaigns should either be
extended to evenings and weekends or to workplaces and schools
[12]. Third, the study did not assess reasons for not linking to care
among persons newly tested HIV-positive who did not enroll in
care within 1 mo. Several studies have shown that interventions
such as follow-up visits or phone calls may improve linkage to care
[37,38]. Fourth, our study was not designed to collect follow-up
data on persons newly diagnosed HIV-positive to assess possible
harms as a consequence of knowing their positive HIV status.
There is a risk of gender-based violence, stigma, or coercion as a
result of a positive HIV test [14,39,40]. In its consolidated ART
guidelines of 2013, WHO reported on the findings of 15 studies
that examined positive and negative consequences of community-
based HIV testing. The reviewed evidence demonstrated neither
reduction nor increase in stigma, fear, or harm through
community-based approaches [40]. During our study, lay coun-
selors were closely supervised by the professional counselor, and
direct individual feedback of the test result—an important ethical
part of any broad HTC activity [41]—was ensured as an
integrated part of the campaigns. All patients testing positive
during the campaigns were followed up by a lay counselor or a
village health worker if they did not link to care within 1 mo. Fifth,
the exclusion criteria in both study groups led to the exclusion of
about one-fifth of persons accessing the campaigns (Figure 1).
About half of exclusions were due to an already known HIV status.
Another important reason for exclusion was persons who stated
that they had their last negative HIV test ,12 wk ago.
The trial was designed and set up to reduce potential bias as
much as possible within a setting that resembles real conditions
and, as such, allows practical conclusions. Inherently to such
setting, we cannot fully rule out that reporting and recording bias
may have occurred. Under the assumption that behavior and
perceptions did not vary between the different groups and clusters,
reporting bias—if present—can be assumed to have occurred
equally distributed between groups. Rotation of the teams between
groups and clusters also reduced the risk of the impact of recording
bias on the final result and conclusion. Although the villages where
the campaigns were conducted were selected according to the
same criteria within each cluster, a selection bias cannot be
excluded. Equally, HB-HTC cannot exclude selection bias of
individual households and persons, given the non-random
selection of households within one village. Nevertheless, we had
decided not to use random sampling of households in HB-HTC, as
MC-HTC does not represent a random sampling either, given
that persons have to decide to attend the community gathering. As
the interventions could not be concealed, a potential detection bias
cannot be excluded. It is important to realize that the interventions
reached different sub-populations. Enrollment of participants was
inherently done within a different recruitment context (HB-HTC
versus MC-HTC) and different conditions. The MC-HTC arm
reached persons who had decided to access the campaign, whereas
HB-HTC reached individuals who were at home while the
campaign was held. This difference was evident in imbalances in
the characteristics of the participants of the two groups. Such
imbalances have been said to challenge the principles of intention
to treat analysis in cluster-randomized trials [42]. Nevertheless,
one of the study’s objectives was exactly to assess differences in
populations met by the two approaches: from a programmatic
point of view, the information about ‘‘which intervention reaches
Table 2. Primary outcomes.
Outcome Sub-Catetgory
HB-HTC Group,
Percent (n/N)
MC-HTC Group,
Percent (n/N) OR (95% CI) p-Value aOR (95% CI)
Adjusted
p-Value
Uptake of HTC Overall 92.5 (1,083/1,171) 86.7 (1,207/1,392) 1.89 (1.44–2.46) ,0.001 2.06 (1.18–3.60) 0.011
By age group
,12 y 87.5 (259/296) 58.7 (209/356) 4.92 (3.29–7.37) ,0.001 4.91 (2.41–10.00) ,0.001
12–24 y 94.7 (197/208) 97.1 (201/207) 0.53 (0.19–1.47) 0.226 0.59 (0.21–1.67) 0.322
$25 y 93.9 (618/658) 96.1 (795/827) 0.62 (0.39–1.00) 0.051 0.61 (0.33–1.13) 0.117
By gender
Men ($12 y) 94.3 (247/262) 97.1 (236/243) 0.49 (0.19–1.22) 0.125 0.49 (0.18–1.29) 0.149
Women ($12 y) 94.2 (565/600) 96.1 (758/789) 0.66 (0.40–1.08) 0.101 0.65 (0.38–1.11) 0.116
Participants newly
detected HIV-positive
3.6 (39/1,083) 6.2 (75/1,207) 0.56 (0.38–0.84) 0.005 0.64 (0.48–0.86) 0.002
Linkage to care after
positive HIV test
25.6 (10/39) 25.3 (19/75) 1.02 (0.42–2.47) 0.971 0.99 (0.35–2.79) 0.978
All aORs and adjusted p-values are adjusted for cluster effect. In non-stratified analyses, aORs and p-values are also adjusted for gender and age group. Missing data for
gender: 6; missing data for age group: 11.
OR, odds ratio.
doi:10.1371/journal.pmed.1001768.t002
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what kind of population’’ is very important. In addition, some
clusters were geographically neighbored, and, as a consequence,
inter-cluster cross-contamination related to aggregate outcome
data at the cluster level 28 d after the campaigns might have
occurred.
To our knowledge, this is the first trial comparing the efficacy of
HB-HTC to that of community-gathering HTC around a mobile
clinic. Apart from the real-life setting of the study, the additional
strength of our study was that it tested both approaches within a
standardized multi-disease campaign setting with equal use of
resources. Furthermore, the study assessed as outcomes not only
HTC uptake but also persons newly detected as HIV-positive and
their subsequent enrollment in care.
Both study arms demonstrated a high HTC uptake of .85%.
At 92.5%, uptake in the HB-HTC group was higher than reported
in the systematic review of community-based HTC approaches by
WHO that calculated an average uptake of 87% for MC-HTC
and 80% for HB-HTC [12]. The higher uptake in our study may
be due to the provision of HTC within a multi-disease campaign,
offering clinical tuberculosis screening and measurement of weight
and height for all individuals, family planning, blood pressure and
blood sugar measurement for adults, and provision of vitamin A,
standard immunizations, and deworming for eligible children and
women. This multi-disease campaign approach may have helped
to reduce the stigma related to HTC, as HTC was only one part of
a broader package of services.
HTC uptake in the HB-HTC group (92.5%) was significantly
higher than in the MC-HTC group (86.7%). This overall
difference was due to a much higher uptake in the age group ,
12 y in the HB-HTC group (Table 2). Interestingly, the propor-
tion of children ,12 y accessing the campaigns was the same in
both groups (Table 1). However, only 59% of childrens’ caregivers
in the MC-HTC group accepted HTC as compared to 88% in the
HB-HTC group (Table 2). This result implies that caregivers’
consent for the child’s HTC is more easily received within the
home than at a mobile clinic.
HB-HTC reached more men for HTC. However, after
adjustment for cluster effect, the difference was not significant
anymore. Previous studies have reported that men are reluctant to
seek group testing in general and suggest that confidential testing at
home may be a better approach to reach this underrepresented
group for HTC [34,35,43]. Furthermore, HB-HTC reached more
first-time testers, particularly among adolescents and young adults.
Given the need to scale up HTC—especially among men, first-time
testers, and children [2,43,44]—our results suggest that HB-HTC
may prove a good approach to reach these population groups.
The prevalence of previously undetected HIV infections was
lower in the HB-HTC group. While the MC-HTC approach may
inherently attract individuals already concerned about their
health, a possible second cause may be the effect of the health
talk during community gatherings on undecided individuals.
Participants may reflect on the information received and make a
decision to test or not according to their personal judgment of their
risk profile, leading to participants with a higher pre-test
probability of infection taking up HTC in the MC-HTC group.
If the goal of an HTC campaign is to maximize the number of
individuals newly diagnosed HIV-positive to consecutively enroll
into care, the community-gathering approach around a mobile
clinic may prove more effective.
Only one out of four participants newly diagnosed HIV-
positive linked to HIV care within 1 mo. Reasons for the
particularly low linkage in our study may be the rural and remote
context, where transport is a major barrier to accessing care [45].
A time period of 3 mo, used in other studies conducted in rural
areas, to assess linkage to care might have resulted in a higher
rate [45]. Moreover, most newly diagnosed persons in our study
Table 3. Proportion of first-time testers, participation of men, and proportion of participants newly tested HIV-positive with
advanced disease.
Outcome Sub-Category
HB-HTC Group,
Percent (n/N)
MC-HTC Group,
Percent (n/N) OR (95% CI) p-Value aOR (95% CI)
Adjusted
p-Value
Proportion of first-time
testers among participants
who took up HTC
Overall 56.2 (609/1,083) 44.4 (536/1.207) 1.61 (1.36–1.89) ,0.001 1.57 (1.03–2.39) 0.035
By age group
,12 y 89.2 (231/259) 76.1 (159/209) 2.59 (1.57–4.29) ,0.001 2.64 (0.76–9.24) 0.128
12 to 24 y 53.8 (106/197) 31.3 (63/201) 2.55 (1.69–3.84) ,0.001 2.47 (1.49–4.08) ,0.001
$25 y 43.2 (267/618) 39.4 (313/795) 1.17 (0.95–1.45) 0.146 1.15 (0.73–1.79) 0.552
Participation of men Proportion of men
among individuals
($12 y) reached
through the campaigns
30.3 (262/866) 23.5 (243/1,034) 1.42 (1.16–1.74) 0.001 1.41 (0.98–2.03) 0.062
Proportion of men who
took up HTC among
individuals ($12 y)
reached through the
campaigns
28.5 (247/866) 22.8 (236/1034) 1.35 (1.10–1.67) 0.004 1.35 (0.92–1.99) 0.129
Proportion of participants
newly tested HIV-positive
with clinical WHO stage 3
or 4 disease
5.1 (2/39) 1.3 (1/75) NA NA NA NA
All aORs and adjusted p-values are adjusted for cluster effect. In non-stratified analyses, aORs and p-values are also adjusted for gender and age group. Missing data for
gender: 6; missing data for age group: 11.
NA, not applicable; OR, odds ratio.
doi:10.1371/journal.pmed.1001768.t003
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were at an oligo-symptomatic stage of disease and had a CD4
count .350 cells/ml. Less advanced stage was associated with
low linkage to care in South Africa and Uganda [38,45]. Two
recent observational studies in South Africa reported low linkage
to care after testing at a mobile clinic. Basset and colleagues
found that within 3 mo, only 10% linked to care in a township in
Durban, whereas Govindasamy et al. reported 51% having
linked to care within the predefined period in peri-urban
townships in Cape Town [32,33]. These studies, as well as our
findings, suggest that mobile HTC campaigns—be it MC-HTC
or HB-HTC—may have a limited effect on timely linkage to care
of previously undiagnosed HIV-positive persons, unless testing is
conducted in combination with effective interventions to improve
linkage to care. Several trials on interventions to improve linkage
to care are still ongoing. Approaches using intensified peer
support, incentives, home-based ART initiation, or short
message service or phone call reminders appear to be promising
interventions [46].
Conclusion
Overall, both study groups achieved a high uptake of HTC,
endorsing the use of community-based multi-disease approaches to
reach populations that may not access facility-based HTC. Based
on our results, the choice between HB-HTC and MC-HTC
should be guided by the intervention’s objective. HB-HTC may be
a preferred option where equity in access to HTC is of concern, or
in a new area to increase coverage of HTC and reach unreached
individuals and groups, such as first-time testers, children, and
men. For routine activities, however, the MC-HTC approach may
prove more appropriate, especially when detection of new HIV
infections is the major goal. In the light of the recent 90-90-90
strategy [47], HB-HTC appears to be a promising approach to
improve coverage of hard-to-reach populations, such as children,
first-time testers, and men—however, only if combined with
effective interventions improving linkage to care.
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Editors’ Summary
Background. Annually, about 2.3 million people become
newly infected with HIV, the virus that causes AIDS by
gradually destroying CD4 cells and other immune system
cells, thereby leaving HIV-infected individuals susceptible to
other serious infections. HIV can be transmitted through
unprotected sex with an infected partner, from an HIV-
positive mother to her unborn child, or through the injection
of drugs with shared needles. Infection with HIV is usually
diagnosed by looking for antibodies to HIV in the blood or
saliva. After diagnosis, the progression of HIV infection is
monitored by regularly counting the number of CD4 cells in
the blood. Initiation of antiretroviral therapy (ART)—a
combination of drugs that keeps HIV replication in check
but that does not cure the infection—is recommended when
an individual’s CD4 count falls below 500 cells/ml or when he
or she develops signs of advanced or severe disease, such as
unusual infections.
Why Was This Study Done? To control HIV/AIDS, HIV
transmission needs to be reduced, and ART delivery needs to
be increased. In settings of high HIV prevalence, universal
coverage of HIV testing and counseling (HTC) is essential if
these goals are to be met. Unfortunately, many people
refuse ‘‘facility-based’’ HTC (HTC delivered at health care
facilities) because they fear stigmatization and discrimina-
tion. Moreover, many people in resource-limited settings
rarely visit health care facilities. Community-based HTC may
be one way to increase the uptake of HTC, particularly
among populations that are hard to reach, such as men and
first-time testers, but which form of community-based HTC
will be most effective? In this cluster-randomized trial, the
researchers ask whether home-based HTC (HB-HTC)—com-
munity-based HTC in which health care workers go door-to-
door to offer HTC to people in their own home—results in a
higher uptake of HTC than HTC delivered through commu-
nity gatherings and mobile clinics (MC-HTC) in two rural
areas in Lesotho. Nearly a quarter of adults are HIV-positive
in Lesotho, but only 61% of people who need ART currently
receive treatment. A cluster-randomized trial compares
outcomes in groups (clusters) of people chosen at random
to receive different interventions.
What Did the Researchers Do and Find? The researchers
allocated 12 clusters, each comprising a health center and its
catchment area, to the HB-HTC or MC-HTC intervention. In the
HB-HTC arm (1,171 participants), HTC teams going door-to-
door delivered a multi-disease campaign that included HTC to
five villages in each cluster. In the MC-HTC arm (1,392
participants), the multi-disease campaign was delivered at
community gatherings with subsequent service provision in
mobile clinics. Overall, HTC uptake was higher in the HB-HTC
arm than in the MC-HTC arm (92.5% and 86.7% uptake,
respectively). Among participants aged $12 years, there was
no significant difference in HTC uptake between the arms,
whereas among children aged ,12 years, HTC uptake was
significantly higher in the HB-HTC arm than in the MC-HTC arm
(87.5% versus 58.7%; a significant difference is a difference
unlikely to have happened by chance). Among individuals who
took up HTC, 3.6% and 6.2% tested positive for HIV in the HB-
HTC arm and MC-HTC arm, respectively. In both arms, only a
quarter of individuals who tested positive accessed HIV care
within a month of their positive test result. Finally, HB-HTC
reached more first-time testers (particularly among adoles-
cents) and tended to reach more men than MC-HTC.
What Do These Findings Mean? These findings suggest
that, in rural Lesotho, both HB-HTC and MC-HTC delivered as
part of a multi-disease campaign can achieve a high uptake
of HTC. Various aspects of the trial design (for example, the
small number of clusters) may limit the accuracy of the
findings reported here. Notably, however, these findings
suggest that the choice between HB-HTC and MC-HTC
should be guided by the objective of the HTC intervention in
specific settings. Where equity of access is of concern and
where increased HTC coverage, particularly among groups in
which HTC coverage is generally poor (including men, first-
time testers, and children), is paramount, HB-HTC may be the
preferred option. By contrast, the MC-HTC approach may be
more appropriate in settings where the detection of new HIV
infections is the major goal. Finally, and importantly, the
findings of this trial highlight the need for further research
into strategies designed to improve the linkage between HIV
testing and enrollment into care.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001768.
N The World Health Organization provides information on all
aspects of HIV/AIDS, including information on HIV
counseling and testing (in several languages)
N Information is available from the US National Institute of
Allergy and Infectious Diseases on HIV infection and AIDS
N NAM/aidsmap provides basic information about HIV/AIDS
and summaries of recent research findings on HIV care and
treatment
N Information is available from Avert, an international AIDS
charity, on many aspects of HIV/AIDS, including informa-
tion on the global HIV/AIDS epidemic, on HIV testing, and
on HIV/AIDS in Lesotho
N The UK National Health Service Choices website provides
information (including personal stories) about HIV/AIDS
N The ‘‘UNAIDS Report on the Global AIDS Epidemic 2013’’
provides up-to-date information about the AIDS epidemic
and efforts to halt it
N Stories about living with HIV/AIDS are available through
Avert and through healthtalk.org
N More information about this trial is available
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